U.S. markets closed
  • S&P Futures

    4,307.00
    -0.75 (-0.02%)
     
  • Dow Futures

    34,124.00
    +6.00 (+0.02%)
     
  • Nasdaq Futures

    13,644.00
    -14.25 (-0.10%)
     
  • Russell 2000 Futures

    2,023.90
    +0.60 (+0.03%)
     
  • Crude Oil

    87.08
    +0.55 (+0.64%)
     
  • Gold

    1,791.20
    +1.50 (+0.08%)
     
  • Silver

    20.08
    -0.00 (-0.02%)
     
  • EUR/USD

    1.0178
    +0.0007 (+0.07%)
     
  • 10-Yr Bond

    2.8240
    +0.0330 (+1.18%)
     
  • Vix

    19.69
    -0.26 (-1.30%)
     
  • GBP/USD

    1.2108
    +0.0014 (+0.12%)
     
  • USD/JPY

    134.1800
    -0.0350 (-0.03%)
     
  • BTC-USD

    24,002.96
    -55.79 (-0.23%)
     
  • CMC Crypto 200

    571.75
    -0.17 (-0.03%)
     
  • FTSE 100

    7,536.06
    +26.91 (+0.36%)
     
  • Nikkei 225

    29,101.33
    +232.42 (+0.81%)
     

Johnson & Johnson Pulls Talc-Based Baby Powder From US, Canada As Cancer Claims Kill Demand

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Johnson & Johnson (NYSE: JNJ) on Tuesday announced it is discontinuing its talc-based baby powder line in the United States and Canada.

What Happened

The New Jersey-based company said the decision came as part of its portfolio assessment related to novel coronavirus (COVID-19), with another 99 products also being permanently discontinued.

It noted that the demand for its talc-based baby powder reduced in the face of thousands of lawsuits claiming the product can cause cancer.

"Demand for talc-based Johnson's Baby Powder in North America has been declining due in large part to changes in consumer habits and fueled by misinformation around the safety of the product and a constant barrage of litigation advertising," Johnson & Johnson said in a statement.

According to the company, the talc-based powder contributed to about 0.5% of its total U.S. Consumer Health business.

It said its cornstarch-based baby powder would continue to be available in the two countries, and the existing inventory of the talc-based powder will also be cleared.

Why It Matters

The talc-based powder will remain available in other countries beside the U.S. and Canada, where demand for the product remains high, the statement read.

Johnson & Johnson recalled a batch of the baby powder in October last year after the Food and Drug Administration found traces of Asbestos, a known carcinogen, in samples from a bottle sold through an online retailer.

Later in December, the company said third-party scientific tests found no trace of Asbestos in the baby powder.

Johnson & Johnson noted it would continue to "vigorously defend" the product in court, even if it has pulled it from North American markets.

Price Action

The company's shares closed 1% lower at $149.02 on Tuesday. The shares traded another 0.3% lower at $148.51.

Image Credit: Wikimedia.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.